Drug intelligence / Profile preview

BlueBiology Ultimate Care

Development stage: Unknown
Lead developer: BlueBiology
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

BlueBiology Ultimate Care is a high-potency probiotic dietary supplement containing 11 distinct probiotic strains with a concentration of 61 billion colony-forming units (CFUs) per serving. It is currently being investigated by Rush University Medical Center in the Phase 2 PURE-LC (Probiotic Use for Recovery Enhancement From Long COVID) clinical trial. The study evaluates the supplement's ability to improve symptoms and quality of life in patients suffering from post-acute COVID-19 syndrome (Long COVID). The product is formulated in acid-resistant capsules to protect the live microorganisms from gastric acid, ensuring delivery to the intestines where they aim to restore gut microbiome diversity and balance, potentially mitigating the systemic inflammatory responses associated with Long COVID.

Brand names: BlueBiology Ultimate CareBlueBiotics Ultimate Care
Other names: Probiotic Agent

Beyond the preview

Go deeper on BlueBiology Ultimate Care.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlueBiology Ultimate Care.

Explore the full profile